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Abstract
Background: Maharishi Amrit Kalash (MAK) is an herbal formulation composed of two herbal mixtures, MAK-
4 and MAK-5. These preparations are part of a natural health care system from India, known as Maharishi Ayur-
Veda. MAK-4 and MAK-5 are each composed of different herbs and are said to have maximum benefit when used
in combination. This investigation evaluated the cancer inhibiting effects of MAK-4 and MAK-5, in vitro and in vivo.
Methods: In vitro assays: Aqueous extracts of MAK-4 and MAK-5 were tested for effects on ras induced cell
transformation in the Rat 6 cell line assessed by focus formation assay. In vivo assays: Urethane-treated mice were
put on a standard pellet diet or a diet supplemented with MAK-4, MAK-5 or both. At 36 weeks, livers were
examined for tumors, sera for oxygen radical absorbance capacity (ORAC), and liver homogenates for enzyme
activities of glutathione peroxidase (GPX), glutathione-S-transferase (GST), and NAD(P)H: quinone reductase
(QR). Liver fragments of MAK-fed mice were analyzed for connexin (cx) protein expression.
Results: MAK-5 and a combination of MAK-5 plus MAK-4, inhibited ras-induced cell transformation. In MAK-4,
MAK-5 and MAK4+5-treated mice we observed a 35%, 27% and 46% reduction in the development of urethane-
induced liver nodules respectively. MAK-4 and MAK4+5-treated mice had a significantly higher ORAC value (P <
0.05) compared to controls (200.2 ± 33.7 and 191.6 ± 32.2 vs. 152.2 ± 15.7 ORAC units, respectively). The
urethane-treated MAK-4, MAK-5 and MAK4+5-fed mice had significantly higher activities of liver cytosolic
enzymes compared to the urethane-treated controls and to untreated mice: GPX(0.23 ± 0.08, 0.21 ± 0.05, 0.25
± 0.04, 0.20 ± 0.05, 0.21 ± 0.03 U/mg protein, respectively), GST (2.0 ± 0.4, 2.0 ± 0.6, 2.1 ± 0.3, 1.7 ± 0.2, 1.7 ±
0.2 U/mg protein, respectively) and QR (0.13 ± 0.02, 0.12 ± 0.06, 0.15 ± 0.03, 0.1 ± 0.04, 0.11 ± 0.03 U/mg protein,
respectively). Livers of MAK-treated mice showed a time-dependent increased expression of cx32.
Conclusion: Our results show that a MAK-supplemented diet inhibits liver carcinogenesis in urethane-treated
mice. The prevention of excessive oxidative damage and the up-regulation of connexin expression are two of the
possible effects of these products.
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Background
Maharishi Amrit Kalash (MAK) is an herbal formulation
composed of two herbal mixtures, MAK-4 and MAK-5.
These preparations are part of a natural health care sys-
tem, known as Maharishi Ayur-Veda [1,2]. MAK-4 and
MAK-5 are each composed of different herbs and are said
to have maximum benefit when used in combination
[3,4]. A large body of research has been published on
these two herbal mixtures, including studies which show
them to have anticancer, anticarcinogenic, and immune
enhancing properties [5-8].
MAK-4 was shown to prevent 7,12-dimethyl-
benz(a)anthracene (DMBA)-induced mammary carci-
noma in rats during both the initiation and promotion
phases of carcinogenesis. Also, when the control animals
that had developed fully-formed tumors were switched
over to a MAK-4 diet, tumor regression was produced in
60% of these animals [9]. In similar experiments, a MAK-
5 diet provided protection during the promotion phase of
carcinogenesis in rats with DMBA-induced mammary car-
cinoma, and 60% of control animals with tumor experi-
enced regression of the tumor when switched to the MAK-
5 diet [10].
A study on an aggressive lung cancer model, known as
Lewis lung carcinoma also showed positive results with
the use of MAK-4. Mice with this cancer who were fed with
MAK-4 in their diet had a 65% reduction in the number of
metastatic nodules and a 45% reduction in the size of the
nodules [11]. In vitro cell culture experiments on mouse
neuroblastoma cells showed that ethanol extracts of MAK-
5 produced morphological and biochemical differentia-
tion of 75% of the cells [12], while, in a further recent
study, MAK-5 potentiate NGF inducing neuronal differen-
tiation in PC12 cells [13]. In a study reported by the
National Cancer Institute (USA), MAK-4 and MAK-5
inhibited processes of neoplastic transformation in rat tra-
cheal epithelial cell lines and human lung tumor cell lines
[14]. At molecular level, MAK-4 increases levels of mRNA
transcripts of two genes that code for hepatic glycosyl-
transferases in the rat. Distinct changes were observed in
glycosyltransferases, in the rat hepatic nodules from
which cancer arises [15].
The scope of the present investigation is to evaluate the
cancer inhibiting effects of MAK-4 and MAK-5 in vitro and
in vivo, and to investigate the possible mechanism of their
action. Extracts of MAK-4 and MAK-5 were tested for their
effects on ras-induced cell transformation in the Rat 6 cell
line, which has been extensively used to study the effect of
various chemicals on the ras oncogene expression [16].
Molecular changes that underpin tumor formation have
been shown to involve activation of ras in different tissues
of humans and animals [17-20].
The in vivo portion of the study was conducted on liver
cancer-susceptible strains of mice [19]. The effect of MAK-
4 and MAK-5 on the prevention of hepatoma induced by
urethane in CH3HeJ, F1 hybrid mice was evaluated.
Free radicals have been implicated in carcinogenesis [21-
24]. Antioxidants, which provide protection against free
radical damage, are present in MAK 4 and MAK-5. The
chemical composition of these herbal mixtures includes
alpha tocopherol, beta-carotene, ascorbate, bioflavonoid,
catechin, polyphenols, trans resveratrol, riboflavin, tannic
acid, and other low molecular weight substances [25].
Therefore, we have evaluated several parameters of anti-
oxidant defense in the animals. We have performed assays
to measure the oxygen radical absorbance capacity
(ORAC) and activities of the enzymes glutathione peroxi-
dase (GPX), glutathione-S-transferase (GST), and
NAD(P)H: quinone reductase (QR).
Connexins are integral membrane proteins constitutive of
gap junctions (gj), ubiquitous intercellular channels that
allow the direct and selective cell-to-cell exchange of small
cytoplasmic molecules and ions. These exchanges were
long thought to play an important role in the regulation
of cell growth, differentiation and functions in a number
of tissues [26]. Connexins comprise a multigenic family,
with each member presenting its own tissue-specific dis-
tribution and whose expression is developmentally regu-
lated [27]. For quite a long time the loss or the alteration
of gap junction intercellular communication (GJIC) was
proposed to play an important role in the process of car-
cinogenesis [28], in particular, when occurring in animal
models as well as in human during hepatocarcinogenesis
[29,30] and after animal exposure to tumor promoting
agents [31].
Several in vitro studies have shown a correlation between
the anticarcinogenic potential of antioxidant molecules
and their ability to up-regulate GJIC and connexin (cx)
expression [32], being these effects cell-type specific as
well [33]. Therefore, the effect of MAK on the expression
of liver-specific members of the connexin family of pro-
teins, namely cx32, cx26 and cx43 [34] was also analysed.
Methods
Chemicals
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carbox-
ylic acid) and 1-chloro-2-4-dinitrobenzene were obtained
from Aldrich Chemical Co. (Milan, Italy). The Chelex 100
resin (200–400 mesh, Na form) was purchased from
Mallinckrodt Inc. (St. Louis, Mo, USA). The Ransel kit was
obtained from Randox (Crumlin, UK). All the other rea-
gents were obtained from Sigma Chemical Co. (Milan,
Italy) unless otherwise indicated.BMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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Herbal mixtures
Maharishi Amrit Kalash-4 (MAK-4) and -5 (MAK-5) were
gifts from the Global Trading Group (Verona, Italy). MAK-
4 is in paste form and contains the following ingredients:
Raw sugar, Ghee, Terminalia Chebula, Emblica Officinalis,
Hooney,  Cinnamon,  Cyperus Rotundus,  Curcuma,  Piper
Longum, Santalum Album, Bacopa Monnieri, Cyperus Scario-
sus, Mesua Ferrea, Convolvulus Pluricaulis, Licorice, Embelia
Ribes. MAK-5 is in tablet form and contains the following
ingredients: Sphaeranthus indicus, Gymnema aurentiacum,
Withania Somnifera, Licorice, Ipomea Digitata, Asparagus
Ascendens,  Acacia Arabica,  Emblica Officinalis,  Tinospora
Cordifolia, Asparagus Racemoso, Vitex Trifolia, Convolvulus
Pluricaulis, Curculigo Orchioides, Capparis Aphylla, Argyrea
Speciosa, Vanda spatulatum, elephant creeper.
Qualitative chemical analysis has revealed that MAK-4
and MAK-5 contain multiple antioxidants, including
alpha-tocopherol, beta-carotene, ascorbate, bioflavonoid,
catechin, polyphenols, riboflavin, tannic acid, and other
low molecular weight substances [25]. The quantitative
analysis of these constituents has not been done. The total
polyphenols were assessed by the reduction of phospho-
tungsticphosphomolybdic acids (Folin Ciocalteu's rea-
gent) by phenols in alkaline solution [35] and sodium
carbonate method. Their concentration in crude dried
material is 21,76 mg per gram. MAK-4 contains 7 µg per
dried gram of crude material of trans-resveratrol deter-
mined by high performance liquid chromatography. The
total antioxidant activity of MAK-4, measured by a modi-
fication of the Ferric Reducing Ability of Plasma (F.R.A.P)
assay is 144 µmol per gram of dried crude material. The
F.R.A.P assay measures the percentage of FeIII
(FeCl3.6H20) reduced to FeII by water extractable antioxi-
dants. Reagents were prepared as indicated by Iris et al.
[36]. The production of MAK-4 and MAK-5 is subjected to
stringent quality control measures, to assure uniform
composition and quality from batch to batch.
Preparation of MAK extracts
Aqueous extracts of MAK-4 or MAK-5 were prepared by
adding 2 mg of the herbal mixture to one ml of near-boil-
ing double distilled water and stirring for 20 minutes. The
suspension was spun at 6000 rpm for 20 minutes, then
the supernatant was collected and filtered with a sterile fil-
ter. The appropriate amount of this stock solution was
then mixed with 2× Dulbecco's Modified Eagle Medium
(DMEM) and double distilled water to prepare a 1×
DMEM medium with the designated dosages of MAK
extract for later usage.
Cell cultures
The Rat 6 cell line is a subclone of the Fisher rat embryo
fibroblast, originally derived by Freeman and colleagues
[37]. All stock cell lines were grown in 90 mm dishes in
DMEM supplemented with 10% calf serum (D10CS)
(Gibco/BRL Co. USA). Cultures were maintained in a
humidified incubator at 37°C with 5% CO2 in air, and fed
twice a week with fresh DMEM plus D10CS.
Cytotoxicity
Rat 6 cells and T24-transformed Rat 6 cells (R6/T24) were
seeded in triplicate at 104 cells per 60 mm plate in D10CS
with the aqueous extracts of MAK-4 and MAK-5. MAK-4
and MAK-5 were first tested at the dosage ranging from
200 to 1000 µg/ml as designated. The cells were main-
tained in the tested mixtures for 5 days. At the end of the
treatment, the cells were trypsinized and counted by Coul-
ter Counter. Cytotoxicity was expressed as percent of cell
survival compared to the untreated control.
Transfection and focus formation assay
The DNA-mediated transfection procedure was essentially
based on the method of Bacchetti and Graham [38] and
Wigler et al, [39] with slight modifications by Hsiao et al.
[16]. Plasmid pT24 containing a 6.4-kilobase BamHI frag-
ment corresponding to the cellular coding sequence of the
mutated human bladder cancer c-H-ras  oncogene was
obtained from Goldfarb et al. [40] and used for the trans-
fection assay. The recipient cells were seeded at 5 × 105 per
90 mm plate in D10CS. One day later, the cells were fed
with fresh D10CS, 4 hours before transfection. Calcium
phosphate-precipitated DNA (1 µg of plasmid DNA plus
20 µg of carrier DNA) was added to each dish and incu-
bated for 4 hours at 37°C. The medium was then removed
and the transfected cells were fed with fresh D10CS. The
next day, the cultures were trypsinized and re-plated in
DMEM plus D5FCS (Foetal Calf Serum) at approximately
2.5 × 105 cells per 90 mm plate. The replated cultures were
fed twice a week with D5FCS throughout the remainder of
the experiment. To determine the effects of MAK-4 and
MAK-5 on ras induced foci formation, aqueous extracts of
the herbal mixtures were added to the transfected cultures
one day after replating and throughout the remainder of
the experiment. Three to 4 weeks after transfection, the
plates were stained with Giemsa stain and scored for
transformed foci.
Animals and treatments
Female C3H/HeN mice and male C57BL/6J mice were
purchased from Charles River (Milan, Italy). C57BL/6J
males were crossed with C3H/HeN females to obtain
CH3-HeJ hybrid mice (a strain of mice with high suscep-
tibility to liver and lung tumorigenesis induced by various
means [41,42]. Only male hybrid mice were used for the
experiments. In one experiment, a group of 85 hybrid
mice was treated at 8 days of age with a single dose of ure-
thane diluted in 0.9% sodium chloride solution, at the
dosage of 300 mg/kg body weight. After weaning, the
mice were separated and put on different diets; 25 miceBMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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were fed a standard pellet diet and 20 mice/group were fed
a pellet diet containing: MAK-4 (4%, w/w) MAK-5 (1%,
w/w) and a combination of MAK-4+5 at the same concen-
trations (diets were prepared by adding commercial prep-
arations of MAK-4 and MAK-5 to the pellet mixture,
Piccioni, Milan). The dose of MAK-4 and MAK-5 was
extrapolated from the recommended human dose, which
is 10 g MAK-4 twice a day and 500 mg MAK-5 twice a day.
All mice had tap water ad libitum and were kept under
observation in the same room. All the surviving animals
were sacrificed at 36 weeks of age and their livers collected
for histological analysis.
A separate experiment was conducted on five groups of
mice (10 mice/group). Two groups of mice were handled
in the same manner as described above (+/- urethane) and
three groups of mice fed a diet supplemented with the
three combinations of MAK. At 36 weeks of age the ani-
mals were sacrificed and their livers and sera collected for
biochemical analysis. The serum samples were stored at -
80°C and the livers were stored in liquid nitrogen until
the time of analysis.
A time-course experiment was conducted on groups of 3-
month-old hybrid mice. The mice were fed the diet sup-
plemented with 4% (w/w) MAK-4 and 1% (w/w) MAK-5
or both, for 3 days, 7 days, 2 weeks, 1 month, or 3
months. The mice were sacrificed at their respective times
and their livers and sera collected for biochemical analy-
sis. The serum samples were stored at -80°C and the livers
were stored in liquid nitrogen until the time of analysis.
A separate time-course experiment was conducted on
CH3-HeJ healthy 3-month-old hybrid mice. The mice
were fed with the MAK-supplemented diet for 1 day, 1
week, 1 month, 2 months, or 3 months. A control group
of CH3-HeJ mice was fed with a standard pellet diet. The
mice were sacrificed at their respective times and their liv-
ers were collected for immunoblot analysis.
The procedures involving the animals and their care were
conducted in accord with institutional guidelines, which
comply with national and international laws and policies
[National Institutes of Health, Guide for the Care and Use
of Laboratory Animals, 1996 (7th edition) (Washington,
D.C.); National Academy Press, National Research Coun-
cil Guide] [43]. Mice were kept in animal rooms main-
tained at a temperature of 23°C, with natural light/dark
cycles.
Liver tumors
The mice were sacrificed at 36 weeks of age. Their livers
were examined for gross lesions, fixed in formaline,
embedded in paraffin, cut, and stained with hematoxylin
and eosin for histopathological examination. For each
mouse, all the visible nodules were counted in two sec-
tions, one from the left liver lobe and one from the
median liver lobe, and the size of the nodules was meas-
ured in cubic millimetres (mm3).
Oxygen radical absorbance capacity of serum
After sacrifice at 36 weeks, the hybrid mice sera were ana-
lyzed for oxygen radical absorbance capacity (ORAC)
using a modified method of Cao et al. [44]. The reaction
mixture for the ORAC assay contained 1.67 × 10-8 M beta-
Phycoerythrin (β-PE), 0.3% H2O2, and 9 × 10-6 M CuSO4
in 7.5 × 10-2 M phosphate buffer, pH 7.0 (200 ml). The
phosphate buffer was passed through Chelex 100 resin
before it was used to prepare the solutions, and was used
as a blank in the assay. The reaction mixture and sera were
pipetted into fluorimetry 96-well microplates. Trolox, a
water-soluble vitamin E analogue, was used as a control
standard. Samples containing β-PE alone (1.67 × 10-8 M in
phosphate buffer) were also prepared to monitor the
spontaneous decay of fluorescence of this indicator pro-
tein under the experimental conditions. H2O2 and CuSO4
were added to each well to generate hydroxyl radicals
(OH°), then the microplate was put into the pre-warmed
plate (37°C) of a Titertek Fluoroscan II (Flow Laborato-
ries, Milan, Italy) and the fluorescence of β-PE was meas-
ured every five minutes until zero fluorescence occurred,
using the excitation and emission wavelengths of 540 nm
and 565 nm, respectively. All fluorescence readings were
automatically corrected for the spontaneous decay of β-
PE.
The ORAC values of the mice sera were calculated by
measuring the net protection area (S) under the quench-
ing curve of β-PE in the presence of the sera. One ORAC
unit was designated as the net protection provided by 1
µM (final concentration) Trolox. The ORAC units of a
sample were calculated as follows: ORAC units = (Ssam-
ple-Sblank)/(S1µM Trolox-Sblank).
Liver cytosolic enzyme activities
Liver homogenates were analyzed for activities of the fol-
lowing enzymes: glutathione peroxidase (GPX), glutath-
ione-S-transferase (GST), and NAD(P)H: quinone
reductase (QR). Homogenates were prepared in a
medium consisting of 140 mM KCl and 25 mM potas-
sium phosphate buffer (pH 7.4), and centrifuged at 6000
× g for 10 minutes. The protein concentration of the sam-
ples (crude extracts) was determined by the method of
Bradford [45].
GPX activity was determined using the commercial Ransel
kit which is based on the principle of NADPH oxidation;
GPX catalyzes the oxidation of glutathione by cumene
hydroperoxide. In the presence of glutathione reductase
and NADPH, the oxidized glutathione is converted to theBMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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reduced form with a concomitant oxidation of NADPH to
NADP+. The decrease in absorbance was measured spec-
trophotometrically at 340 nm. For each determination,
samples containing 5 µg liver protein were used.
GST activity was assayed as previously reported [46].
Briefly, a solution of 1 mM glutathione and 1 mM 1-
chloro-2-4-dinitrobenzene in 0.1 M phosphate buffer, pH
6.5, was added to samples containing 10 µg of liver pro-
tein. The increase in absorbance was read spectrophoto-
metrically after 1, 2, and 3 minutes at 340 nm.
QR activity was measured as described previously [47].
Briefly, 420 µl of a mixture containing 25 mM Tris, pH
7.4, 0.7 mg/ml bovine albumin, 0.01% Tween 20, 1.07
mM glucose-6-phosphate, 2.15 U/ml glucose-6-phos-
phate dehydrogenase, 5.35 µM FAD, 32 µM NADP, and
321 mg/l MTT were added to 50 µl of sample. After the
addition of 5 mM menadione in acetonitrile (10 µl/ml),
the reaction was carried on for 5 minutes and the absorb-
ance read spectrophotometrically at 610 nm. In order to
determine the proportion of MTT reduction attributable
to QR, another set of samples was pre-treated in the pres-
ence of 0.3 mM dicoumarol in 0.5% DMSO and 5 mM
potassium phosphate (pH 7.4) and assayed as described
above. For each determination, samples containing 150
µg liver protein were used.
Measurement of connexin expression by immunoblot 
analysis
The influence of the MAK-supplemented diet on the
expression of the three liver-specific connexins (cx26,
cx32, and cx43), was measured. For the immunoblot anal-
ysis, the Western blot technique was used. Fragments of
liver from control mice fed a normal diet or mice fed the
MAK-supplemented diet for 1 day, 1 week, 1 month, 2
months, or 3 months were prepared and alkali-extracted
[30]. Alkali-resistant membrane proteins, corresponding
to approximately 15 µg of total protein/sample, were
resolved on 12.5% SDS-PAGE [48] and then transferred
onto a nitrocellulose membrane (Schleicher and Schuell,
Keene, NH, USA). As a control for normalizing the
amount of samples, the gels were stained with 0.25%
Comassie Blue solution (R 250/G 250, 1:1) (Bio Rad Lab-
oratories, Hercules, CA, USA).
Membranes were hybridized with mouse anti-cx26
(1:750) (Zymed Laboratories Inc., San Francisco, CA,
USA), anti-cx32 (1:1000) (Chemicon International Inc.
Temecula, CA, USA), or anti-cx43 (1:1000) (Chemicon
International Inc. Temecula, CA, USA) monoclonal anti-
bodies, followed by reaction with peroxidase-conjugated
anti-mouse IgG (1:2000) (Amersham International, Buck-
inghamshire, UK). Immunopositive reaction was detected
by the enhanced chemiluminescence (ECL, Amersham,
Buckinghamshire, UK) method.
Statistical analysis
Statistical analysis was performed by Two Way ANOVA
Test followed by Post Hoc Bonferroni analysis.
Results
Effect of MAK-4 and MAK-5 on H-ras-induced cell 
transformation assessed by focus formation assay
MAK-4 and MAK-5 were initially tested for their inhibi-
tory effects in H-ras-induced cell transformation at 500
µg/ml in Rat 6 cells (Table 1). MAK-4 exerted no or
slightly enhancing effect on the formation of transformed
foci, while MAK-5 exhibited 92% reduction compared to
the untreated control.
MAK-4 and MAK-5 were slightly toxic. At 500 µg/ml, the
survival rate of the MAK-4 and MAK-5 treated cells were
83% and 69% respectively compared to controls.
MAK-4 and MAK-5 were also tested at 200, 500, and 1000
µg/ml (Table 2). MAK-5 was inhibitory on the formation
of H-ras-foci, while MAK-4 seemed to enhance cell trans-
formation. The enhancement effect was most prominent
when cultures were treated with a low dosage of MAK-4.
Table 1: Effect of MAK-4 and MAK-5 on H-ras-induced cell transformation in Rat 6 cells
Treatment Exogenous H-ras gene Cytotoxicity (% survival) Foci/plate ± SD Relative number of foci**
None - 100 0 0.0
None + 100 15.3 ± 2.5 1.00
MAK-4 (500 µg/ml) + 79 13.0 ± 1.7 0.84
MAK-5 (500 µg/ml) + 73 1.2 ± 1.3 0.078
Rat 6 cells transfected with an activated H-ras oncogene were replated in D5FCS growth medium at ~2.5 × 105/90 mm plates as described in 
Materials and Methods. The treatment groups were fed with D5FCS plus the herbal extracts one day after replating and throughout the remainder 
of the experiment. All cultures were fed twice a week. At day 18 from the time of transfection, the cultures were fixed with 10% formaldehyde, 
stained with Giemsa stain, and scored for transformed foci by focus formation assay. Triplicate plates were used for each experimental group. 
Cytotoxicity was based on cell numbers of each treatment group counted by Coulter Counter and expressed as percent of cell survival compared 
to the untreated control. ** The relative number of foci is the number of foci obtained from the treatment groups divided by those obtained from 
the no-treatment group.BMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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To test the combinatory effect of MAK-4 and MAK-5, 500
µg/ml of MAK-5 were tested alone or in the presence of
200 and 500 µg/ml of MAK-4. As reported in Table 3,
although MAK-4 alone showed no effect on H-ras-foci, it
slightly enhanced the inhibitory effect of MAK-5 by 10%.
Effect of MAK-4 and MAK-5 on the growth of normal and 
transformed Rat 6 cell lines
To determine whether or not the inhibition on ras-foci
was due to a differential killing of ras-transformed cells,
MAK-4 and MAK-5 were tested for their cytotoxic effect on
a fully established clonal ras transformed cell line R6/T24.
In the same experiment, normal Rat 6 cells were also
included in the test (Table 4). MAK-4 and MAK-5 slightly
stimulated the growth of Rat 6 at 200 µg/ml, while exerted
mild toxicity at 500 µg/ml. At 1000 µg/ml, the cytotoxic
effect of MAK-5 became evident. Rat 6 cells were more
sensitive than the transformed R6/T24 to MAK-5 cytotox-
icity (Table 4). This result suggests that the inhibitory
effect of MAK-5 extract on foci formation is not a result of
direct cell killing of the transformed cells, instead, it may
exert its effect at an early stage of ras-induced transformed
foci.
Liver tumors
The effect of MAK-4 and MAK-5 was tested in vivo in CH3-
HeJ hybrid male mice as indicated in materials and meth-
ods. There was a significant reduction in the number of
mice that developed liver tumor nodules in the MAK-fed
groups, compared to controls. All the 34 mice that were
treated with urethane and fed the normal diet developed
liver tumors at the age of 36 weeks, whereas only 54% of
the urethane-treated mice (69 mice) on the diet supple-
mented with MAK showed nodule formation (23 mice on
MAK-4, 22 on MAK-5 and 24 on MAK-4+5) (Figure 1,
Panel A).
Among the tumor-positive mice, the number of nodules
was significantly lower in the groups fed with combina-
tion of MAK-4+5 (3.2 ± 1.9, 4.0 ± 2.2, 1.8 ± 1.0 vs. 6.1 ±
3.0 nodules/mouse, respectively) (Figure 1, Panel B). The
average size of the nodules was similar in the MAK-fed
and control groups (data not shown).
Oxygen radical absorbance capacity (ORAC)
The ORAC value was significantly higher (P < 0.05) in the
urethane-treated mice fed a diet supplemented with MAK-
4 and a combination of MAK-4+5, compared to the con-
trols (Figure 2, Panel A).
Time-course experiments performed in the 3-month-old
hybrid mice fed with the effective MAK-4+5 combination,
showed a progressive increase in ORAC which reached
significance at 7 days after starting the MAK-supple-
Table 3: Combinatory effect of MAK-4 and MAK-5 on H-ras-induced transformation assessed by focus formation assay
Treatment Exogenous H-ras gene Cytoxicity (% survival) Foci/plate ± SD Relative number of foci
Mock control - 100 0 -
None + 100 81.7 ± 2.3 1.00
MAK-5, 500 µg/ml plus MAK-4, 0 µg/ml + 65 25.3 ± 2.7 0.52
MAK-5, 500 µg/ml plus MAK-4, 100 µg/ml + 81 17.7 ± 0.9 0.28
MAK-5, 500 µg/ml plus MAK-4, 200 µg/ml + 88 20.3 ± 0.8 0.31
The experimental procedure and the duration of treatment was the same as Table 1.
Table 2: Dosage effect of MAK-4 and MAK-5 on H-ras-induced cell transformation in Rat 6 cells
Treatment Exogenous H-ras gene Cytotoxicity (% survival) Relative number of foci
Mock control - 100 0
None + 100 1.0
MAK-4:
200 µg/ml + 132 1.75
500 µg/ml + 98 1.29
1000 µg/ml + 92 1.35
MAK-5:
200 µg/ml + 135 0.69
500 µg/ml + 64 0.28
1000 µg/ml + 48 0.26
Data were obtained from two individual experiments by focus formation assay. Triplicate plates were used for each experiment. Experimental 
procedures were the same as indicated in Table 1.BMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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mented diet. The ORAC value reached its maximum at 1
month and this level was maintained for the course of the
experiment (Figure 2, Panel B).
Liver cytosolic enzyme activities
Liver homogenates were analysed for activity of the
enzymes: Glutathione peroxidase (GPX) activity was
higher in homogenates of the urethane-treated mice fed a
diet supplemented with MAK-4, MAK-5 and MAK-4+5,
compared to controls. Glutathione-S-transferase (GST)
was significantly higher in all the groups treated with MAK
and NAD(P)H: quinone reductase (QR) activity was
higher in the mice fed with MAK-4 and MAK4+5, com-
pared to controls (Figure 3, Panel A).
Results of a time-course experiments in 2-month-old
hybrid mice fed with the most effective combination
MAK-4+5 showed a progressive increase in the activities of
GPX, GST, and QR, which began to be detectable after 1
day on the MAK-supplemented diet. A significant increase
(P < 0.05) was seen at 1 week for all the samples. The high-
Oxygen radical absorbance capacity (ORAC) Figure 2
Oxygen radical absorbance capacity (ORAC). Oxygen 
radical absorbance capacity (ORAC) in urethane-treated 
mice on MAK-supplemented diets, urethane-treated mice on 
a normal diet, and control mice on the normal diet (Panel A). 
The time-course experiment was performed on healthy male 
mice put on the MAK4+5-supplemented diet (for 0, 3 days, 1 
week, 2 weeks,1 month, or 2 months) without any previous 
treatment (Panel B). One ORAC unit represents the equiva-
lent ORAC activity of 1 µmol Trolox. (* P < 0.05). Each 
group of animals was composed of 10 mice. At 36 weeks of 
age the mice were sacrificed, the serum collected and stored 
at -80°C until the day of the assay. Data are reported as 
mean ± SEM of three experiments. Statistical analysis was 
performed by Two Way ANOVA Test followed by Post Hoc 
Bonferroni analysis.
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Table 4: Dosage effect of MAK-4 and MAK-5 on the growth of transformed Rat 6 cells
Treatment Cells (× 106/60 mm plate) ± SD % of survival
Rat 6 R6/T24* Rat 6 R6/T24
None (control) 0.94 ± 0.04 1.32 ± 0.04 100 100
MAK-4:
200 µg/ml 1.24 ± 0.12 1.52 ± 0.05 138 141
500 µg/ml 0.94 ± 0.08 1.27 ± 0.06 112 115
1000 µg/ml 0.82 ± 0.09 1.29 ± 0.07 91 119
MAK-5:
200 µg/ml 1.57 ± 0.09 1.77 ± 0.09 119 164
500 µg/ml 0.84 ± 0.08 1.07 ± 0.04 84 101
1000 µg/ml 0.58 ± 0.06 0.73 ± 0.01 66 79
R6/T24 is a permanent cell line transformed by an activated human c-H-ras oncogene. Both normal and H-ras transformed Rat 6 cells were seeded 
in triplicate at 104 cells per 60 mm plate in D10CS. Next day, cultured were switched to D5FCS, or FCS plus herbal extracts at designated dosages 
for 5 days. At the end of the treatment, cells were trypsinized and counted by Coulter Counter. Cytotoxicity was expressed as percent of cell 
survival compared to the untreated control.
Histological analysis of mice livers Figure 1
Histological analysis of mice livers. Hybrid F1 mice were 
injected with urethane (300 mg/kg) at 8 days of age. A group 
was then put on a MAK-supplemented diet, another group 
was fed a standard pellet diet. At 36 weeks of age the mice 
were sacrificed and the livers examined for the presence of 
tumors mouse (Panel A) and for the number of nodules per 
mouse (Panel B) (* p < 0.05, ** P < 0.001). Statistical analysis 
was performed by Two Way ANOVA Test followed by Post 
Hoc Bonferroni analysis.
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est levels were reached at 1 month for all three enzymes
(Figure 3, Panel B).
Expression of gap junction proteins in the liver
We than measured the influence of the MAK-4+5 combi-
nation on the expression of the three liver-specific con-
nexins (cx26, cx32, and cx43). The level of cx26
expression was similar in all the groups of mice treated
with the MAK-supplemented diet and in the control (Fig-
ure 4, Panel A). A significant, time-dependent increase in
cx32 was observed in the liver of all the groups of MAK
treated mice compared to the normal diet-fed controls.
Cx32 expression increased 2-fold after 1 week of treat-
ment, and 3- to 4-fold at 3 months (Figure 4, Panel B).
The anti cx32 antibody reacted with two antigens with
molecular masses of 27 kDa and 48 kDa. The 48 kD band
was identified as a stable dimeric form of cx32, as previ-
ously reported [49].
Discussion
The present study reveals the ability of MAK-4 and MAK-5
to inhibit cell transformation induced by ras oncogene in
an in vitro cell system and in vivo liver carcinogenesis in
mice.
The group of mice fed a diet supplemented with a combi-
nation of MAK-4 and MAK-5, had a 46% reduction in the
number of liver nodules, compared to mice that were fed
a normal diet. Among the tumor-positive mice, the
number of tumor nodules was significantly lower in the
MAK fed mice. The ability of MAK-4 and MAK-5 to inhibit
carcinogenesis may be due to several different mecha-
nisms that may be difficult to identify. The complex mix-
ture of these preparations will not allow the identification
of effects due to single components, until extract fraction-
ation is performed. Here we have investigated the ability
of MAK-4 and MAK-5 to scavenge free radicals and reac-
tive oxygen species (ROS) and regulate connexins, which
are markers of tissue integrity and tumor formation. Free
radical-mediated reactions such as lipid peroxidation are
implicated in carcinogenesis [21] and there is increasing
evidence that the initiation and promotion phases of can-
cer is favoured by free radical reactions [22-24]. Thus,
antioxidants which act to control the oxidative state may
represent a major line of defense against cancer develop-
ment. Multiple antioxidants are present in MAK-4 and
MAK-5 such as alpha-tocopherol, beta-carotene, ascor-
bate, bioflavonoid, catechin, polyphenols, riboflavin, and
tannic acid and many others that are still uncharacterized
[25]. A Previous research has shown that these mixtures of
Western blot analysis of gap junction proteins cx26 and cx32  in mouse liver Figure 4
Western blot analysis of gap junction proteins cx26 
and cx32 in mouse liver. Equal amounts of alkali-resistant 
membrane proteins (corresponding to 15 µg total lysate) 
were loaded in each lane. The same membrane was probed 
with anti-cx26 and anti-cx32, subsequently. Lanes: normal 
diet-fed (control: C); 1 d (1 day); 1 w (1 week); 1 m (1 
month); 2 m (2 months);3 m (3 months) of MAK-4+5 supple-
mented diet. Panel A: Anti-cx26 antibody; a 21 kDa band 
indicates the presence of cx26 protein. Panel B: Anti-cx32 
antibody; two bands of 27 kDa and 48 kDa were detected 
corresponding, respectively, to the monomeric and dimeric 
forms of the cx32 protein. Panel C: Anti-actin antibodies 
hybridization. Results are representative of three independ-
ent immunoblots.
C  1d  1w 1m 2m 3m    time A
B
C
CX26
CX32, dimeric
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actin
Enzyme activities in mice Figure 3
Enzyme activities in mice. Enzyme activities in mice 
treated with urethane plus MAK-supplemented diets, ure-
thane-treated mice on a normal diet, and control mice on the 
normal diet. (Panel A). The time-course experiment was per-
formed on healthy male mice put on the MAK-4+5 supple-
mented diet (for 3 day, 1 week, 2 weeks,1 month, or 2 
months) without any previous treatment. Each group was 
composed of 10 mice. At 36 weeks of age the mice were sac-
rificed, the livers collected and stored in liquid nitrogen until 
the day of the assay. Data are reported as mean ± SEM of 
several experiments. (* P < 0.05 and ** P < 0.001). Statistical 
analysis was performed by Two Way ANOVA Test followed 
by Post Hoc Bonferroni analysis.
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chemicals scavenge free radicals and ROS such as superox-
ide, hydroxyl, and peroxyl radicals, and hydrogen perox-
ide generated in both cellular (neutrophil) and
noncellular (xanthine-xanthine oxidase) systems [50], in
a dose-dependent manner. MAK-4 and MAK-5 inhibit the
in vitro peroxidation of lipids in rat liver microsomes
[51,52], reduce lipid peroxide levels and inhibit the oxida-
tion of low-density lipoprotein (LDL) [53-55].
In the present work, the antioxidant properties of MAK-4
and MAK-5 were confirmed in vivo in mice. The oxygen
radical absorbance capacity (ORAC) assay measured a sig-
nificantly higher value in mice fed the MAK supplemented
diet, which increased progressively from day 7 and
reached a maximum level at 1 month that was maintained
throughout the course of the experiment.
Another line of antioxidant defense was evaluated by
measuring the activity of the liver enzymes GPX, GST and
QR. All these enzymes were upregulated in the MAK-fed
mice. It is known that many compounds that block toxic,
mutagenic, and neoplastic effects of carcinogens have in
common the ability to elevate levels of phase II detoxifica-
tion enzymes such as GST and QR [56]. Inducers of phase
II enzymes, present in fruits and vegetables, have been
shown to prevent carcinogenesis [57]. Substantial evi-
dence has accumulated to suggest that the induction of
phase II enzymes is a causal mechanism for protection
since these enzymes divert ultimate carcinogens from
reacting with critical cellular macromolecules [57]. Epide-
miological evidence links a diet rich in antioxidants from
fruits and vegetables with a low risk of cancer [58]. How-
ever, the optimal intake of antioxidants may not be
achievable by diet alone: natural compounds and natural
food supplements may be of help to reach an effective
antioxidant protection, particularly in subgroups of the
population at high risk of developing cancer. Accumulat-
ing evidences suggest that several antioxidant com-
pounds, irrespective of their structure, may counteract the
promotive action of chemicals by interfering with the oxi-
dant-dependent down-regulation of gap junction func-
tion [59]. This possibility was explored by evaluating the
effect of MAK on liver specific connexins expression. Gap
junctions are specialized intercellular membrane in which
connexins are regulated developmentally and in a tissue-
specific manner [27]. Altered connexins expression has
been proved to occur during the carcinogenic process
[28]. Since restoration of normal GJIC appears to work as
tumor suppressive element, GJIC is being exploited as end
point for identification of cancer chemopreventive agents
[28]. In vivo, hepatocytes express at least three different
connexins, cx32, cx26 and cx43 [34]. Cx32 levels were
much higher in the MAK-fed mice compared to the con-
trol. These findings indicate that MAK enhance gap junc-
tional communication in liver of CH3-HeJ mice and may
support previous in vitro findings which demonstrate that
oxygen radical scavengers induce liver-specific cx expres-
sion in cultured hepatocytes [59]. Thus the antioxidant
induced up-regulation of cx expression may be considered
as a possible mechanism for the cancer-preventive proper-
ties of MAK.
The in vitro studies here reported show that MAK-5 pro-
duced a 92% reduction in the ras-induced cell transforma-
tion. MAK-4 did not have the same effect: on the contrary
it showed a slight enhancement of cell transformation.
Both MAK-4 and MAK-5 were found to be slightly toxic to
the Rat 6 cell line; however, they had no apparent toxic
effect on the ras-transformed cell line R6/T24. It is there-
fore very unlikely that the inhibitory effect of the MAK-5
extract on foci formation is the result of direct cell killing
of the transformed cells, but instead it may exert its effect
on the process of transformation by the H-ras oncogene.
The discrepancy between the in vitro and in vivo data, with
regard to their anticarcnogenic properties, might be due to
the fact that the in vitro experiments were performed with
a water soluble fraction of MAK-4 and -5. Extraction may
have out selected fractions of several chemicals that are
important for the activity of MAKs, which relative solubil-
ity in not known.
Literature data indicate that another possible mechanism
for the anticarcinogenic properties of MAK-4 and MAK-5
is the enhancement of immunity, that has been demon-
strated in several previous studies in which animals
treated with MAK-5 had a 32–88% increase in mitogen-
induced lymphocyte proliferation. This enhanced
immune functioning lasted as long as 15 days after dis-
continuation of MAK-5 treatment. Macrophage superox-
ide anion generation and phagocytosis were unchanged
during MAK-5 treatment, indicating that the protective
abilities of the macrophages were unaltered [60]. In a sep-
arate study, lymphocytes from mice that were fed MAK-5
in their diet had higher proliferative responses to activa-
tion by phytohemagglutinin and anti-CD3 antibodies.
The spontaneous rate of lymphocyte proliferation was not
increased by MAK-5. Peritoneal macrophages from the
mice fed MAK-5 showed an increase in tumor cell killing,
when activated with either interferon or lipopolysaccha-
ride. Moreover, activated macrophages from MAK-5-fed
mice produced significantly more nitric oxide than con-
trol animals. Nitric oxide is considered an important
mediator in the tumoricidal and bactericidal actions of
macrophages. Both nitric oxide production and cytotoxic-
ity were inaltered by MAK-5 in the inactivated macro-
phages [6]. Hence, MAK-5 induces in vivo priming of both
T cells and macrophages, resulting in enhanced function-
ing of the immune system.BMC Complementary and Alternative Medicine 2007, 7:19 http://www.biomedcentral.com/1472-6882/7/19
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Immunological studies conducted by other groups con-
firmed these observations [8]. These authors showed that
MAK-4 has similar immune-enhancing properties as
MAK-5 [8]. In addition, MAK-4 significantly increased
stimulated splenic production of interleukin-2, that is
involved in the regulation of the immune system. Another
group investigated the dose-dependent activation of
immune functioning in mice treated with MAK-5. They
showed that the daily assumption of MAK-5 at the dose of
50 mg/kg, enhanced macrophage functioning as well as
lymphocyte responsiveness [61]. Altogether these studies
indicate that the anticarcinogenic activities of MAK may
also be a result of enhanced functioning of the immune
system.
Conclusion
The present study demonstrates that MAK-4 and MAK-5
inhibit liver carcinogenesis in mice. These herbal mixtures
also increase antioxidant defenses and liver-specific con-
nexin expression, both of which may be involved in the
mechanism of action of the anticancer potential of these
compounds.
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